In this update we are covering the news stories from June/July 2023, keeping you informed whether you are managing your own diabetes or doing so as a carer.
Libre 2 becomes real-time CGM
New Dexcom product to target Type 2s
FDA Approves Mobi Insulin Pump
The FDA (Food and Drug Administration) ie. US Regulator, has cleared the Tandem Mobi insulin pump for use in managing diabetes in the US.
The pump unit is less than half the size of the t:slim X2 and is now the smallest available tubed pump in the world. It is fully controllable from a mobile app through a compatible smartphone.
Progress on Diabetes Cure using Stem Cells
Vertex recently announced that they have made big strides towards a cure for type 1 diabetes using stem cells.
Over a year after receiving the company’s stem-cell therapy, two type 1 diabetes patients no longer need to take insulin injections.
Trials for 6 patients using Vertex's VX-880 engrafted islet cells have shown that all are self-secreting insulin. Tests also show the patients have improved their HbA1c levels, time-in-range and a reduction or elimination of external insulin use (pump or MDI).
|By 2050 it is expected that over 1.3 billion people will be living with diabetes - more than double the number now and affecting every country and age group.